StockWatch
·

KREBS BIOCHEMICALS & INDUSTRIES LTD.-$ Q4 FY25 Results

KREBSBIOQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue6.1046.8%
Total Income6.4445.0%
Expenditure14.6924.5%
PBT-8.256.6%
Net Profit-8.276.8%
OPM-88.64%9.59pp
NPM
EPS3.83206.7%
View full financials

Informational and educational content only. Not investment advice.